Ali Tehrani - Jul 12, 2021 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Jul 12, 2021
Transactions value $
-$403,079
Form type
4
Date filed
7/13/2021, 08:00 PM
Next filing
Jul 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYME Common Shares Options Exercise $54.6K +12.7K +4.87% $4.31 273K Jul 12, 2021 Direct F1, F2
transaction ZYME Common Shares Sale -$458K -12.7K -4.64% $36.12* 260K Jul 12, 2021 Direct F1, F3
holding ZYME Common Shares 55.5K Jul 12, 2021 Held by spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Options Exercise $0 -12.7K -21.97% $0.00 45K Jul 12, 2021 Common Shares 12.7K $4.31 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to a 10b5-1 plan entered into May 13, 2021.
F2 The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.3062 using the Bank of Canada exchange rate for July 12, 2021 (CAD1.00 = $0.8019).
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.0649 to $36.5902, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 12, 2021 at each separate price.
F4 Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of January 1, 2012 and (ii) remainder of underlying shares in 36 equal monthly installments on the last day of month following first anniversary of grant date.